Evoke Pharma, Inc. (EVOK)

NASDAQ: EVOK · IEX Real-Time Price · USD
+0.01 (0.72%)
At close: Oct 2, 2023, 4:00 PM
-0.11 (-7.91%)
After-hours: Oct 2, 2023, 7:32 PM EDT

Total Valuation

Evoke Pharma has a market cap or net worth of $4.65 million. The enterprise value is $2.69 million.

Market Cap 4.65M
Enterprise Value 2.69M

Important Dates

The next estimated earnings date is Wednesday, November 8, 2023, after market close.

Earnings Date Nov 8, 2023
Ex-Dividend Date n/a

Share Statistics

Evoke Pharma has 3.34 million shares outstanding. The number of shares has increased by 5.90% in one year.

Shares Outstanding 3.34M
Shares Change (YoY) +5.90%
Shares Change (QoQ) n/a
Owned by Insiders (%) 2.46%
Owned by Institutions (%) 2.07%
Float 3.26M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.30
Forward PS 1.70
PB Ratio 8.63
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.75
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.29, with a Debt / Equity ratio of 9.39.

Current Ratio 4.29
Quick Ratio 3.86
Debt / Equity 9.39
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -14.86

Financial Efficiency

Return on equity (ROE) is -258.20% and return on invested capital (ROIC) is -148.50%.

Return on Equity (ROE) -258.20%
Return on Assets (ROA) -71.60%
Return on Capital (ROIC) -148.50%
Revenue Per Employee $892,562
Profits Per Employee -$1.98M
Employee Count 4
Asset Turnover 0.32
Inventory Turnover 0.99


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -26.46% in the last 52 weeks. The beta is 0.36, so Evoke Pharma's price volatility has been lower than the market average.

Beta (1Y) 0.36
52-Week Price Change -26.46%
50-Day Moving Average 1.27
200-Day Moving Average 2.15
Relative Strength Index (RSI) 66.18
Average Volume (30 Days) 14,493

Short Selling Information

The latest short interest is 17,726, so 0.53% of the outstanding shares have been sold short.

Short Interest 17,726
Short Previous Month 3,643
Short % of Shares Out 0.53%
Short % of Float 0.54%
Short Ratio (days to cover) 1.06

Income Statement

In the last 12 months, Evoke Pharma had revenue of $3.57 million and -$7.93 million in losses. Loss per share was -$2.36.

Revenue 3.57M
Gross Profit 3.18M
Operating Income -7.56M
Pretax Income -7.93M
Net Income -7.93M
EBIT -7.43M
Loss Per Share -$2.36
Full Income Statement

Balance Sheet

The company has $7.01 million in cash and $5.05 million in debt, giving a net cash position of $1.95 million or $0.58 per share.

Cash & Cash Equivalents 7.01M
Total Debt 5.05M
Net Cash 1.95M
Net Cash Per Share $0.58
Equity / Book Value 538,374
Book Value Per Share 0.16
Working Capital 6.85M
Full Balance Sheet

Cash Flow

Operating Cash Flow -6.44M
Capital Expenditures n/a
Free Cash Flow -6.44M
FCF Per Share -$1.93
Full Cash Flow Statement


Gross margin is 89.14%, with operating and profit margins of -211.80% and -222.06%.

Gross Margin 89.14%
Operating Margin -211.80%
Pretax Margin -222.06%
Profit Margin -222.06%
EBITDA Margin -204.88%
EBIT Margin -208.05%
FCF Margin -180.51%

Dividends & Yields

Evoke Pharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -170.61%
FCF Yield -138.69%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -5.90%
Shareholder Yield -5.90%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on May 23, 2022. It was a reverse split with a ratio of 1:12.

Last Split Date May 23, 2022
Split Type Reverse
Split Ratio 1:12